CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
8.67
-0.16 (-1.81%)
At close: Jul 9, 2026, 4:00 PM EDT
8.70
+0.03 (0.37%)
After-hours: Jul 9, 2026, 7:48 PM EDT
CorMedix Market Cap
CorMedix has a market cap or net worth of $680.18 million as of July 9, 2026. Its market cap has decreased by -36.21% in one year.
Market Cap
680.18M
Enterprise Value
649.51M
1-Year Change
-36.21%
Ranking
Category
Stock Price
$8.67
Market Cap Chart
Since May 13, 2010, CorMedix's market cap has increased from $34.20M to $680.18M, an increase of 1,888.82%. That is a compound annual growth rate of 20.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 680.18M | -25.77% |
| Dec 31, 2025 | 916.30M | 86.43% |
| Dec 31, 2024 | 491.50M | 138.48% |
| Dec 29, 2023 | 206.10M | 18.31% |
| Dec 30, 2022 | 174.20M | 0.52% |
| Dec 31, 2021 | 173.30M | -27.40% |
| Dec 31, 2020 | 238.70M | 27.78% |
| Dec 31, 2019 | 186.80M | 37.45% |
| Dec 31, 2018 | 135.90M | 304.46% |
| Dec 29, 2017 | 33.60M | -45.72% |
| Dec 30, 2016 | 61.90M | -13.79% |
| Dec 31, 2015 | 71.80M | 67.76% |
| Dec 31, 2014 | 42.80M | 114.00% |
| Dec 31, 2013 | 20.00M | 143.90% |
| Dec 31, 2012 | 8.20M | 156.25% |
| Dec 30, 2011 | 3.20M | -84.62% |
| Dec 31, 2010 | 20.80M | -39.18% |
| May 13, 2010 | 34.20M | - |
View and export this data all the way back to 2010. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prime Medicine | 720.66M |
| Candel Therapeutics | 711.45M |
| SL Science Holding | 701.45M |
| First Tracks Biotherapeutics | 689.47M |
| Neurogene | 684.39M |
| Tectonic Therapeutic | 676.27M |
| BridgeBio Oncology Therapeutics | 667.29M |
| 4D Molecular Therapeutics | 664.95M |